These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 4870533)

  • 21. Psychedelic drugs and creativity.
    Krippner S
    J Psychoactive Drugs; 1985; 17(4):235-45. PubMed ID: 4087078
    [No Abstract]   [Full Text] [Related]  

  • 22. [Classic psychedelic drugs and their potential therapeutic effect].
    Bayat M
    Ugeskr Laeger; 2017 Sep; 179(37):. PubMed ID: 28918777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological aspects of hallucinogenic drugs.
    Logan WJ
    Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
    [No Abstract]   [Full Text] [Related]  

  • 24. Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.
    Ezeaka UC; Kim HJJ; Laprairie RB
    Curr Top Med Chem; 2023; 23(23):2232-2241. PubMed ID: 37409550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hallucinogen abuse.
    Haddad LM
    Am Fam Physician; 1976 Jul; 14(1):82-7. PubMed ID: 1065215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mescaline, LSD, psilocybin, and personality change.
    UNGER SM
    Psychiatry; 1963 May; 26():111-25. PubMed ID: 13995386
    [No Abstract]   [Full Text] [Related]  

  • 27. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
    Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The psychology of hallucinogenic drug discontinuers.
    Salzman C; Lieff J; Kochansky GE; Shader RI
    Am J Psychiatry; 1972 Dec; 129(6):755-61. PubMed ID: 4404760
    [No Abstract]   [Full Text] [Related]  

  • 30. The hallucinogens and the inhalants.
    Cohen S
    Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.
    HOLLISTER LE; SJOBERG BM
    Compr Psychiatry; 1964 Jun; 5():170-8. PubMed ID: 14156873
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular insights into psychedelic drug action.
    Slocum ST; DiBerto JF; Roth BL
    J Neurochem; 2022 Jul; 162(1):24-38. PubMed ID: 34797943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current status of the hallucinogenic drugs.
    Seal RE
    Aust N Z J Psychiatry; 1970 Jun; 4(2):64-7. PubMed ID: 5286790
    [No Abstract]   [Full Text] [Related]  

  • 34. Hallucinogenic drugs.
    Anesth Analg; 1968; 47(1):72-6. PubMed ID: 4866081
    [No Abstract]   [Full Text] [Related]  

  • 35. HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS.
    CHARALAMPOUS KD; KINROSS-WRIGHT J
    Tex State J Med; 1963 Sep; 59():848-52. PubMed ID: 14054727
    [No Abstract]   [Full Text] [Related]  

  • 36. Cessation and reduction in alcohol consumption and misuse after psychedelic use.
    Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW
    J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The abuse of psychodelics: a social and medical problem].
    Nowak S; Herman Z
    Pol Tyg Lek; 1970 May; 25(19):698-701. PubMed ID: 4912910
    [No Abstract]   [Full Text] [Related]  

  • 38. Hallucinogens.
    Brown RT; Braden NJ
    Pediatr Clin North Am; 1987 Apr; 34(2):341-7. PubMed ID: 3550656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES.
    TOLAN EJ; LINGL FA
    Am J Psychiatry; 1964 Feb; 120():757-61. PubMed ID: 14117647
    [No Abstract]   [Full Text] [Related]  

  • 40. [APROPOS OF OPTIC DISORDERS IN AUTOEXPERIMENTS WITH HALLUCINOGENS].
    GROF S
    Cesk Psychiatr; 1964 Jun; 60():173-82. PubMed ID: 14177526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.